Full-scale counteroffensive! Hong Kong-listed AI stocks surge back—has the correction ended?

Just moments ago, the market staged a major rally!

China Securities JournalJul 21 12:10

S&P Global Market Intelligence's latest list of the top 10 Hong Kong-listed stocks with the highest short interest ratios is led by Montage Technology (06809.HK).

S&P Global Market Intelligence released short interest data for Hong Kong-listed stocks as of last Friday (the 17th). The 'short interest ratio' is defined as the percentage of shares on loan relative to the total number of issued shares. The current average short interest ratio for the Hang Seng Index constituents stands at 1.33%. The following table lists the top ten Hong Kong-listed stocks with the highest short interest ratios, as provided by S&P Global Market Intelligence: Stock Name │ Shares on Loan (millions) │ 7-Day Change (%) │ Short Interest Ratio (%) │ 7-Day Price Change (%) Montage Technology (06809.HK) │

AASTOCKSJul 21 10:54

On-site Coverage of the World Artificial Intelligence Conference: Fund Managers Survey Three Key Areas

The strongest signal emerging from this year’s exhibition is that AI is rapidly moving beyond 'concept demonstrations' and into the physical world—many of the new products showcased are no longer lab prototypes but mature, mass-producible, and deployable solutions.

China Securities JournalJul 20 21:16

Alibaba Health Information Technology Stock Advances 2.7% in Hong Kong

Dow JonesJul 20 16:32

Ali Health Hydrogen Ion has reached a content collaboration agreement with the NEJM Group.

Sina Tech News, July 20 (afternoon) — Ali Health's medical AI platform, Hydrogen Ion, has officially announced a content partnership with the NEJM Group (publisher of The New England Journal of Medicine). Under the agreement, all NEJM Group publications and multimedia resources dating back to 1990—including NEJM, NEJM Evidence, NEJM AI, NEJM Catalyst, and NEJM Clinician—have been licensed to Hydrogen Ion. Hydrogen Ion will become the only medical AI platform in China authorized by NEJM to provide full-text reading services to individual physician users.

Sina TechnologyJul 20 15:33

Hong Kong Stock Market Movement | PharmaEssentia-B (02565) Rises Over 5% as It Joins Forces with Three Parties to Accelerate Commercialization of Pidilizumab, Poised for Market Expansion

Phage BioPharma-B (02565.HK) rose more than 5%. As of the time of writing, it was up 5.41% at HK$7.01, with a market capitalization of HK$1.32 billion.

Zhitong FinanceJul 20 11:43